These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30547005)

  • 1. Higher hemoglobin A1C and atherogenic lipoprotein profiles in children and adolescents with type 2 diabetes mellitus.
    Pelham JH; Hanks L; Aslibekyan S; Dowla S; Ashraf AP
    J Clin Transl Endocrinol; 2019 Mar; 15():30-34. PubMed ID: 30547005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index and glycemic control influence lipoproteins in children with type 1 diabetes.
    Vaid S; Hanks L; Griffin R; Ashraf AP
    J Clin Lipidol; 2016; 10(5):1240-7. PubMed ID: 27678442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON.
    Lorenzatti AJ; Monsalvo ML; López JAG; Wang H; Rosenson RS
    Cardiovasc Diabetol; 2021 Apr; 20(1):94. PubMed ID: 33941192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overweight adolescents with type 2 diabetes have significantly higher lipoprotein abnormalities than those with type 1 diabetes.
    Hanks LJ; Pelham JH; Vaid S; Casazza K; Ashraf AP
    Diabetes Res Clin Pract; 2016 May; 115():83-9. PubMed ID: 27242127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol.
    Colhoun HM; Leiter LA; Müller-Wieland D; Cariou B; Ray KK; Tinahones FJ; Domenger C; Letierce A; Israel M; Samuel R; Del Prato S
    Cardiovasc Diabetol; 2020 Feb; 19(1):14. PubMed ID: 32035487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.
    Fonseca L; Paredes S; Ramos H; Oliveira JC; Palma I
    Lipids Health Dis; 2020 Jun; 19(1):127. PubMed ID: 32505210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Lefrandt JD
    Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes mellitus.
    Sellers EA; Yung G; Dean HJ
    Pediatr Diabetes; 2007 Dec; 8(6):384-90. PubMed ID: 18036065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HDL-cholesterol in an adolescent diabetes population.
    Kuryan RE; Jacobson MS; Frank GR
    J Clin Lipidol; 2014; 8(2):194-8. PubMed ID: 24636179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles.
    Amor AJ; Castelblanco E; Hernández M; Gimenez M; Granado-Casas M; Blanco J; Soldevila B; Esmatjes E; Conget I; Alonso N; Ortega E; Mauricio D
    Cardiovasc Diabetol; 2020 Aug; 19(1):126. PubMed ID: 32772924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia.
    Hussain A; Ali I; Ijaz M; Rahim A
    Ther Adv Endocrinol Metab; 2017 Apr; 8(4):51-57. PubMed ID: 28507727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
    Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
    Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Status and Race are Associated with Cardiovascular Risk Markers in Obese Adolescents.
    Colvin CW; Ashraf AP; Griffin RL; Diaz BT; Yannam GR; Johnson JE; Lucas AP; Propst M; Harmon CM
    Endocr Pract; 2015 Feb; 21(2):165-73. PubMed ID: 25297661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes.
    Weinstock RS; Goldberg RB; Guyton JR; Mazzone T; Polis A; Tomassini JE; Lin J; Shah A; Tershakovec AM
    J Clin Lipidol; 2008 Feb; 2(1):25-35. PubMed ID: 21291712
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.